A Study to Assess Imaging Studies of Neurodegenerative and Related Disorders

Overview

Información sobre este estudio

The purpose of this study is to perform longitudinal assessments in patients with neurodegenerative and related disorders to better understand the underlying cause/s which will help with the development of future treatments and prognosis.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • All subjects will be over the age of 21.
  • Must have symptoms suggestive of a neurodegenerative and/or related disorder;  i.e., patients must have one or more neurological symptom that is insidious in onset and has worsened over time in nature.

Exclusion Criteria:

  • Subjects will be excluded if they have any concurrent illnesses that could account for all of their symptoms, such as traumatic brain injury, encephalitis, strokes or developmental syndromes.
  • Women that are pregnant or post-partum and breast-feeding will be excluded.
  • All women who can become pregnant must have a pregnancy test before the PET/CT scan.
  • Subjects will be excluded if they have any of the following genetic conditions which can increase the chance of cancer:
    • Cowden disease;
    • Lynch syndrome;
    • Hypogammaglobulinemia;
    • Wiskott-Aldrich syndrome;
    • Down’s syndrome.
  • Subjects will be excluded from undergoing the MRI if it is contraindicated (metal in head, cardiac pace maker, etc), if there is severe claustrophobia, if there are conditions that may confound brain imaging studies (e.g., structural abnormalities, including subdural hematoma, intracranial neoplasm or large cortical infarcts), or if they are medically unstable or are on medications that might affect brain structure or metabolism (e.g., chemotherapy).

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Keith Josephs, M.D.

Abierto para la inscripción

Contact information:

Sarah Boland CCRP

(507) 284-3863

Boland.Sarah@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20493021

Mayo Clinic Footer